chrisvoncsefalvay/vaers-outcomes huggingface dataset:
he has chronic myeloid leukemia - white blood cell count is higher; His oxygen is low; Blood clot in his legs; first dose on 19Jan2021 and second dose on 02Feb2021; first dose on 19Jan2021 and second dose on 02Feb2021; This is a spontaneous report from a contactable nurse reported for her father that an 82-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 02Feb2021 at single dose for covid-19 immunisation. Medical history included chronic myeloid leukemia (CML). Concomitant medications were not reported. Patient previously received first dose of BNT162B2 on 19Jan2021 at single dose for covid-19 immunisation. Patient received Pfizer-BioNTech COVID-19 Vaccine first dose on 19Jan2021 and second dose on 02Feb2021. Two days after second dose (04Feb2021) he had to go to the hospital - he had chronic myeloid leukemia - white blood cell count was higher (Feb2021), he had been in the hospital for the last 3 days as of 08Feb2021, his oxygen was low, had a blood clot in his legs, had a bone marrow biopsy, all on an unspecified date in Feb2021. The nurse is taking its related to this vaccine and assessed this case as not serious.  Outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Since the first vaccine, i started and still have up to date hot flashes daily and some equal librium issues.
pt. recvd 2nd dose hepatitis B vac, later p/ingesting 2 shrimp was unable to swollow. Dysphagia spontaneously resolved. recvd 3rd dose w/o incident.
throwing up the night of the vaccine and multiple times in the following two weeks of my second dose, haven't thrown up in over a decade history of UTI's but haven't gotten one in months, got one the week after getting my second dose random body aches in the following two weeks after my second dose
Received DTaP in the left thigh, later mom noticed redness and swelling in the same area. No fever. Was screaming nonstop for many hours and mom noticed redness in the mouth. Denies any lip swelling. No breathing problems. No generalized rash or hives. No vomiting today. Vomited 2 times yesterday. No diarrhea. No seizure activity.
severe seasonal allergy symptoms; Headache; Extended migraine. severe intermittent aural effects (loss of vision, shots of light, looks snow on a TV); tingling in limbs- hands, toes, left side of face; This is a spontaneous report received from a contactable consumer (patient).  This 39-year-old female patient (no pregnant ) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 20Mar2021 14:00 (Lot Number: ER8727) at single dose for COVID-19 immunization. Medical history included allergy: allergies to medications, food, or other products was not known. Concomitant medications included ascorbic acid, cobalt sulfate, copper sulfate, ergocalciferol, ferrous fumarate, magnesium sulfate, manganese sulfate, nicotinamide, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, thiamine hydrochloride, tocopherol, vitamin b12 nos, zinc gluconate (MULTIVITAMIN (16)); oenothera biennis oil (EVENING PRIMROSE); cetirizine for allergy. The patient experienced severe seasonal allergy symptoms, headache, extended migraine with severe intermittent aural effects (loss of vision, shots of light, looks snow on a TV) tingling in limbs, hands, toes, and left side of face on 21Mar2021 at 23:45. Symptoms had come and go 10 and more times a day, but seemed to be decrease in frequency and severity lessening. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was no diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. Seriousness criteria: results in death, life threatening, caused/prolonged hospitalization, disabling/incapacitating, congenital anomaly/birth defect was no. Treatment received for the adverse events included Tylenol. The outcome of the events was recovering.
Healthy Male two months after receiving second dose of vaccine experienced Temporary Ischemic Attack due to vascular clotting.
Cant use muscles in right arm; Swelling right arm; Right arm Pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (right arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injected limb mobility decreased (Verbatim: Cant use muscles in right arm), swelling arm (Verbatim: Swelling right arm) and pain in arm (Verbatim: Right arm Pain). The outcome of the injected limb mobility decreased, swelling arm and pain in arm were not resolved.   It was unknown if the reporter considered the injected limb mobility decreased, swelling arm and pain in arm to be related to Shingrix.     It was unknown if the company considered the injected limb mobility decreased, swelling arm and pain in arm to be related to Shingrix.   Additional Information: GSK receipt date: 27-OCT-2023 The reporter was the patient. The patient experienced pain and swelling in her right arm and could not use her muscles. The patient was not forthcoming to elaborate on the adverse event.  No further information was given during this phone call.
Within four hours of vaccination, fever began that continued throughout the night and spiked to 103 Fahrenheit with Tylenol to manage it. Nausea began shortly after fever started; vomiting started partway through the night, time unknown. Severe headache began in the afternoon of the shot and lasted through the following afternoon.
Horrible pain in the site of the vaccination, inability to move the arm, weakness, and soreness.
axillary nerve damage; fatigue in left arm; vaccinated aroud Fall of 2020 , declined to get 2nd dose; This case was reported by a physician via sales rep and described the occurrence of nerve damage in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced nerve damage, fatigue and incomplete course of vaccination. On an unknown date, the outcome of the nerve damage and incomplete course of vaccination were unknown and the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the nerve damage and fatigue to be related to Shingrix.     Additional Information: GSK Receipt Date: 30-MAR-2022 Reporter's Comment: The patient vaccinated with first dose of Shingrix around fall of 2020 and experienced fatigue in left arm and had not made a full recovering. The diagnosis was axillary nerve damage. The patient declined from receiving second dose. Additional supportive information:  Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Blood pressure up and down; Heart rate goes high when standing; Heart rate goes very low when sitting; Blurred vision; Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (Blood pressure up and down), HEART RATE INCREASED (Heart rate goes high when standing), HEART RATE DECREASED (Heart rate goes very low when sitting), VISION BLURRED (Blurred vision) and DIZZINESS (Dizziness) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE FLUCTUATION (Blood pressure up and down), HEART RATE INCREASED (Heart rate goes high when standing), HEART RATE DECREASED (Heart rate goes very low when sitting), VISION BLURRED (Blurred vision), DIZZINESS (Dizziness) and HEADACHE (Headache). At the time of the report, BLOOD PRESSURE FLUCTUATION (Blood pressure up and down), HEART RATE INCREASED (Heart rate goes high when standing), HEART RATE DECREASED (Heart rate goes very low when sitting), VISION BLURRED (Blurred vision), DIZZINESS (Dizziness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment details were provided
Information has been received from a nurse concerning multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # L025598 with expiration date 13-JAN-2017 and lot # L037924 with expiration date 22-JUN-2017, oral, dose unspecified), which was exposed to temperature excursion 30 Fahrenheit degree (F) for 10 total cumulative hours. It was also reported that there was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Postural orthostatic tachycardia syndrome (POTS); Dizziness; Headache; Autonomic Dysfunction; Orthostatic Intolerence; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 27-year-old female patient (pt). Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. On an unspecified date, the pt was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection (lot#, expiration date, dose, route of administration and anatomical location were not reported) as prophylaxis. On an unspecified date in 2013, the pt experienced following vaccination, postural orthostatic tachycardia syndrome, orthostatic intolerance, autonomic nervous system imbalance, headache and dizziness.  The outcome of all the events was not provided. The reporter considered all events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). This is one of multiple cases from the same reporter.; Sender's Comments:  US-009507513-2301USA007523: US-009507513-2301USA007522: US-009507513-2301USA007498: US-009507513-2301USA007521:
On 6/11/01, pt received DT, HIB, IPV and Prevnar and within 1 hour, pt had 4 hours of uncontrollable crying. At 4 month shots, pt had 4 hours of uncontrollable crying, same shots. On 4/17/01, pt had DTAP, IPV, HIB and Prevnar and had 3 hours of uncontrollable screaming.
Large local reaction - Red, swollen, warm area involving entire R anterior thigh from just below hip to just above knee. Treated with cool compresses and BENADRYL, resolved approximately in 72 hours. All began approximately 2-3 hr after receiving flu vaccine at that location.
Burning right arm; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on the left arm on 11Jan2021 09:30 at a single dose for COVID-19 immunization. The patient had no medical history. There were no concomitant medications. On 15Jan2021, the patient experienced burning right arm and fatigue. Treatment was received for the adverse events which included MRI, NCS, Blood work. The events resulted to a doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Arm was a little tender; Arm was red; Arm was swollen-like; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was a little tender), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE SWELLING (Arm was swollen-like) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was a little tender), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE SWELLING (Arm was swollen-like). At the time of the report, VACCINATION SITE PAIN (Arm was a little tender), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE SWELLING (Arm was swollen-like) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
POST VACCINATION SYNCOPE.  AFTER RECEIVING VACCINE WAS DIRECTED TO WAITING AREA.   WHILE SITTING IN CHAIR FELT FAINT AND STARTED TO GO DOWN.  AMMONIA AMP OPENED AND ADMINISTERED, ASSISTED TO FLOOR IN SUPINE POSITION.  EMS WAS ON SITE, BP 136/82, HR 92 O2 SAT 97, O2 ADMINISTERED VIA NASAL CANNULA.
Redness, swelling, warm, size is about 3 inches oval in right arm.
Moderna COVID-19 Vaccine EUA. Migraine headache, fever, dizzyness, hot/cold flashes, pain in the left arm, and intense body aches.
This initial spontaneous case, was received from other non-health professional (consumer) on 19-Oct-2017, concerning a 52-year-old, adult, female patient. The patient's historical condition included injection site soreness (every year after vaccination). The patient's current condition included hypothyroidism (since an unspecified date). The patient's concomitant medication included levothyroxine for an unknown indication. On 17-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number; 00844611A, expiry date: 29-Jun-2017, anatomical location: left deltoid, route of administration: intramuscular). On 18-Oct-2017, 13 hrs 25 min after vaccination, the patient's arm was sore, which was almost immobile and pain was so bad. The injection site was little sore and she could not use her arm. It was reported that, if she held her arm against her chest, then she did not feel the pain and could raise her arm above her head without pain but as soon as she started to lower her arm, the patient was severe. She felt like her bone was bruised (a deep pain) and she could hardly sleep last night (as reported). Anytime she moved her arm, the pain was severe. On 19-Oct-2017, this morning (as reported), pain was worse and pain was also in her hand. She felt numbness in hand and feet. She used ICY HOT patches (one time) and massage for the treatment of the events. The reporter stated that, her condition would get better. It was reported that, the pain was recovered after 5 days and other events were ongoing (not recovered). The reporter assessed the events as non-serious. Follow up received on 08-Nov-2017: The route of administration (intramuscular), anatomical location (left deltoid) and outcome of the event pain from not recovered to recovered after 5 days were updated. The narrative was amended accordingly.
Pt failed to respond p/ recving 3 doses of hep B vax on 0,1 & 6 month schedule.  HBSAB test indicated lack of immunity.
My right leg feels numbness and tingling. When I bend down I feel dizzy and get headache.
Both arms started hurting at 3:30pm by 11:30pm she was weak, dizzy and her arms aches. Temp 102. Awoke at 3am with chills and severe body ache, nausea, no vomiting. Had rabies vaccine in veterinary school in 2000. Does not know brand. Only SX was headache, 10/19/06 pt got severe stiff neck and headache 10/13/06 about 10pm lasted 24 hours and disappeared spontaneously.
Allergic reaction started in arm about a hour after given.  throat got swollen but not closed  went to walk in clinic they gave: epi, steriod shot, sent home with steriod oral, antihistamine and hydroxyzine.   She is fine and no reactions since
Patient received under diluted dose of Pfizer 5-11 vaccine. No adverse side effects reported at this time.
pt reports extreme pain in rt posterior & lateral neck on movement, along w/severe h/a, not relieved w/Lortab, nausea; throbbing @ inject site @ affected arms et neck;
Intense itching in upper L arm. Area hot, some swelling, red, blotchy.  sweaty/clamy.  No shortness of breath, swelling of lips,tongue.  Refused Benadryl. Refused epinephrine injection. Area iced and patient observed closely. Itching, warmth, reddness disappeared approximately 45 minutes after flu injection
Sweating a lot after second dose; Fatigue after second dose; Headache after second dose; Muscle Pain  after second dose; Joint Pain after second dose; Fever 98.7 F (Usually 98.2 F) after second dose; Chills after second dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating a lot after second dose), FATIGUE (Fatigue after second dose), HEADACHE (Headache after second dose), MYALGIA (Muscle Pain  after second dose) and ARTHRALGIA (Joint Pain after second dose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 22-Jul-2021, the patient experienced HYPERHIDROSIS (Sweating a lot after second dose), FATIGUE (Fatigue after second dose), HEADACHE (Headache after second dose), MYALGIA (Muscle Pain  after second dose), ARTHRALGIA (Joint Pain after second dose), PYREXIA (Fever 98.7 F (Usually 98.2 F) after second dose) and CHILLS (Chills after second dose). At the time of the report, HYPERHIDROSIS (Sweating a lot after second dose), FATIGUE (Fatigue after second dose), HEADACHE (Headache after second dose), MYALGIA (Muscle Pain  after second dose), ARTHRALGIA (Joint Pain after second dose), PYREXIA (Fever 98.7 F (Usually 98.2 F) after second dose) and CHILLS (Chills after second dose) outcome was unknown.            Treatment medication was not provided
Onset of severe bifrontal headache, blurry vision, and "bad taste/smell" within several minutes of vaccine--very similar to initial Moderna vaccine reaction.   Vision normalized within minutes and headache gradually faded over 10-15 min.  No rash or breathing difficulties.  Some retching initially that patient attributed to "bad taste."  Discharged home after prolonged (30 min) observation. Hx of Covid-19 infection in 11/2020 with taste and smell issues at that time as well.
Pt states covered in rash over trunk, feet, ankle, front & back of leg, apex of hip joint, outer edge gluteal area. No rash on genitals. Burning/tingling on cheeks & tongue. Went to ER. Received injections: epinephrine, prednisone, Benadryl & Prilosec. Advised to follow up with allergist. Per pt. rash cleared up when awakened 6/20/13 a.m. Residual 2-3 small hives/near axilla area bilaterally.
Acute onset tachycardia, lethargy tremulous.  Decreased O2 sat, sent to ER via 911.  8/5/08 Reviewed hospital medical records of 5/21/08. FINAL DX: allergic reaction & UTI Records reveal patient experienced shaking & chills, increased BP & pulse, SOB.  Had temp of 99 in ER, P 102, R 22, BP 188/91.  Tx w/IV antihistamine.  D/C to home on oral antibiotic.  8/15/08 Reviewed PCP med records of 5/21-5/28/08. FINAL DX: none provided Records reveal patient experienced tremors, tachycardia & HTN on 5/21 & was sent to ER.  On 5/27 reported episodes of lightheadedness, weakness, tachycardia & feeling faint daily since vaccination.  Referred for Holter monitor.
Hi,  I got my Moderna 1st dose.  Shortly after, I felt light headed with a metal taste in my mouth.  After 45 minutes I was no longer light headed so I left. Driving  home I noticed my tongue felt numb and large (although it looked normal).  Similar to the sensation after novicane after dental work. The sensation got worse to the point that I noticed it was felt different and uncomfortable swallowing my food (especially the back of my tongue).  It cleared up 4-5 hours later starting with the front of my tongue feeling normal and progressing to the back of my tongue/throat.  I did not affect my speech.  That night it felt like the beginning of an asthma attack but I?m not sure if that was due to Spring allergies Or Moderna.  It never developed into asthma  The following 7 days I have an upset stomach.
rash; This case was reported by a physician via call center representative and described the occurrence of rash in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine and now the patient experienced rash on the face.  This is 3 of 4 cases reported by same reporter.
body aches began followed a day later by asthma problems which devel into pneumonia; recvd Amoxil, Pred, Bi-axin; body aches, soreness & h/a; signs of depression in the last wk; persistent cough; tightness in chest;
Same day as shots spiked an extremely high fever 103 and a rash near injection. Called nurses hotline at Clinic was told this is normal. Next day even higher fever 104, full body rash and began to sieze. Took her to the ER. They gave her TYLENOL and prescribed TYLENOL and MOTRIN for fever. Was told to follow up with PCM. Her rash did not go away and she seized on and off. By the time we saw her PCM her rash was going down and her seizure had stopped. Was told by the PCM that she doesn't have anymore vaccines for a while so she should be OK she has complained of her legs hurting and we monitor her for seizures anytime her temperature gets high.
Began having diarrhea within a week of first injection.  This lasted roughly 2 months during which I lost 30 pounds (and counting).  Unclear if this is actually an adverse reaction or part of something else. I have lost the use of my left leg (starting in Nov/2020) over the last 6 months. Institute is treating me for this, but they don?t think the diarrhea is part of whatever is going on with my leg.